BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9276715)

  • 1. Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction.
    Carballo E; Gilkeson GS; Blackshear PJ
    J Clin Invest; 1997 Sep; 100(5):986-95. PubMed ID: 9276715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.
    Carrick DM; Lai WS; Blackshear PJ
    Arthritis Res Ther; 2004; 6(6):248-64. PubMed ID: 15535838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element.
    Fukae J; Amasaki Y; Yamashita Y; Bohgaki T; Yasuda S; Jodo S; Atsumi T; Koike T
    Arthritis Rheum; 2005 Sep; 52(9):2697-707. PubMed ID: 16142751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
    Sugihara M; Tsutsumi A; Suzuki E; Wakamatsu E; Suzuki T; Ogishima H; Hayashi T; Chino Y; Ishii W; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Arthritis Rheum; 2007 Jul; 56(7):2160-9. PubMed ID: 17599736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transcriptional regulation of proinflammatory proteins.
    Anderson P; Phillips K; Stoecklin G; Kedersha N
    J Leukoc Biol; 2004 Jul; 76(1):42-7. PubMed ID: 15075353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival.
    Johnson BA; Geha M; Blackwell TK
    Oncogene; 2000 Mar; 19(13):1657-64. PubMed ID: 10763822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages.
    Jalonen U; Lahti A; Korhonen R; Kankaanranta H; Moilanen E
    Biochem Pharmacol; 2005 Mar; 69(5):733-40. PubMed ID: 15710351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways.
    Johnson BA; Blackwell TK
    Oncogene; 2002 Jun; 21(27):4237-46. PubMed ID: 12082611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the function, expression, and subcellular distribution of human tristetraprolin.
    Brooks SA; Connolly JE; Diegel RJ; Fava RA; Rigby WF
    Arthritis Rheum; 2002 May; 46(5):1362-70. PubMed ID: 12115244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
    Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
    Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.
    Taylor GA; Carballo E; Lee DM; Lai WS; Thompson MJ; Patel DD; Schenkman DI; Gilkeson GS; Broxmeyer HE; Haynes BF; Blackshear PJ
    Immunity; 1996 May; 4(5):445-54. PubMed ID: 8630730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome.
    Carballo E; Blackshear PJ
    Blood; 2001 Oct; 98(8):2389-95. PubMed ID: 11588035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells.
    Suzuki E; Tsutsumi A; Goto D; Matsumoto I; Ito S; Otsu M; Onodera M; Takahashi S; Sato Y; Sumida T
    Int J Mol Med; 2006 May; 17(5):801-9. PubMed ID: 16596264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Mar; 484():1-290. PubMed ID: 12571679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.
    Shoda H; Fujio K; Yamaguchi Y; Okamoto A; Sawada T; Kochi Y; Yamamoto K
    Arthritis Res Ther; 2006; 8(6):R166. PubMed ID: 17078892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages.
    Jalonen U; Paukkeri EL; Moilanen E
    J Pharmacol Exp Ther; 2008 Aug; 326(2):514-22. PubMed ID: 18469159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.
    Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T
    Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.